PET/CT scan to help find early lung cancer
Part of Cancer clinical trials.
This trial tests a special PET/CT scan to spot early lung cancer by finding specific body processes linked to cancer. It compares scan results in people with lung nodules that are either cancer (lung adenocarcinoma) or likely benign.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- A CT scan shows at least one lung nodule that is 1 cm or larger
- You will join either the cancer group (lung adenocarcinoma confirmed by biopsy or surgery) or the benign group (likely non-cancer based on nodule guidelines, lung-RADS 1–3)
- You are not currently pregnant
- You do not have diabetes
- You are not taking SGLT2 inhibitor pills or metformin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET imaging scan to help doctors see how well pembrolizumab (an immunotherapy drug) is working against advanced non-small cell lung cancer. You'll receive the scan along with your regular pembrolizumab treatment and possible radiation therapy to help measure treatment response.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study uses a special PET/CT scan to better tell if a lung nodule is non-small cell lung cancer. If you have a solid nodule in your lung that's at least 8 mm and might be cancer, this scan could help get a clearer diagnosis.
This trial uses artificial intelligence and special imaging tests, like PET/CT and low-dose CT, to find lung cancer early in people at higher risk. It aims to improve how we spot and understand early signs of lung cancer.
This Phase 3 study tests how well a special PET/CT scan medicine (a slightly modified sugar) helps doctors investigate your condition. The goal is to improve how diseases like cancer, brain disorders, heart problems, or infection/inflammation are evaluated.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.